Chikungunya fever: a threat to global public health

References

• Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond). 1956;54:177–191.10.1017/S0022172400044442
   PubMedGoogle Scholar
• Thiboutot MM, Kannan S, Kawalekar OU, et al. Chikungunya: a potentially emerging epidemic? PLoS Negl Trop Dis. 2010;4(4):e623.10.1371/journal.pntd.0000623
   PubMed Web of Science ®Google Scholar
• Halstead SB. Reappearance of chikungunya, formerly called Dengue, in the Americas. Emerg Infect Dis. 2015;21(4):557–561.
   PubMed Web of Science ®Google Scholar
• Powers AM, Brault Robert BAC, Tesh RB, et al. Re-emergence of chikungunya and o’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol. 2000;81:471–479.10.1099/0022-1317-81-2-471
   PubMed Web of Science ®Google Scholar
• Volk SM, Chen R, Tsetsarkin KA, et al. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol. 2010;84(13):6497–6504.10.1128/JVI.01603-09
   PubMed Web of Science ®Google Scholar
• Weaver SC, Forrester NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res. 2015;120:32–39.10.1016/j.antiviral.2015.04.016
   PubMed Web of Science ®Google Scholar
• Cunha RVD, Trinta KS. Chikungunya virus: clinical aspects and treatment – a review. Mem Inst Oswaldo Cruz. 2017;112(8):523–531.10.1590/0074-02760170044
   PubMed Web of Science ®Google Scholar
• Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the indian ocean outbreak. PLoS Med. 2006;3(7):e263.10.1371/journal.pmed.0030263
   PubMed Web of Science ®Google Scholar
• Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010;8(7):491–500.10.1038/nrmicro2368
   PubMed Web of Science ®Google Scholar
• Burt FJ, Chen W, Miner JJ, et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017;17(4):e107–e117.10.1016/S1473-3099(16)30385-1
   PubMed Web of Science ®Google Scholar
• Honório NA, Câmara DCP, Calvet GA, et al. Chikungunya: an arbovirus in the process of establishment and expansion in Brazil. Cad Saude Publica. 2015;31(5):906–908.10.1590/0102-311XPE020515
   PubMed Web of Science ®Google Scholar
• Chen R, Wang E, Tsetsarkin KA, et al. Chikungunya virus 3′ untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces. PLoS Pathog. 2013;9(8):e1003591.10.1371/journal.ppat.1003591
   PubMed Web of Science ®Google Scholar
• Wahid B, Ali A, Rafique S, et al. Global expansion of chikungunya virus: mapping the 64-year history. Int J Infect Dis. 2017;58:69–76.10.1016/j.ijid.2017.03.006
   PubMed Web of Science ®Google Scholar
• Singh SK, Unni SK. Chikungunya virus: host pathogen interaction. Rev Med Virol. 2011;21(2):78–88.10.1002/rmv.681
   PubMed Web of Science ®Google Scholar
• Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99(3):345–370.10.1016/j.antiviral.2013.06.009
   PubMed Web of Science ®Google Scholar
• van Duijl-Richter M, Hoornweg T, Rodenhuis-Zybert I, et al. Early events in Chikungunya virus infection from virus cell binding to membrane fusion. Viruses. 2015;7(7):3647–3674.10.3390/v7072792
   PubMed Web of Science ®Google Scholar
• Das PK, Merits A, Lulla A. Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity. J Biol Chem. 2014;289(9):5635–5653.10.1074/jbc.M113.503433
   PubMed Web of Science ®Google Scholar
• Utt A, Das PK, Varjak M, et al. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2. J Virol. 2015;89(6):3145–3162.10.1128/JVI.03213-14
   PubMed Web of Science ®Google Scholar
• Karpe YA, Aher PP, Lole KS. NTPase and 5′-RNA triphosphatase activities of chikungunya virus nsP2 protein. PLoS One. 2011;6(7):e22336.10.1371/journal.pone.0022336
   PubMed Web of Science ®Google Scholar
• Akhrymuk I, Kulemzin SV, Frolova EI. Evasion of the innate immune response: the old world alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II. J Virol. 2012;86(13):7180–7191.10.1128/JVI.00541-12
   PubMed Web of Science ®Google Scholar
• Fros JJ, Liu WJ, Prow NA, et al. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol. 2010;84(20):10877–10887.10.1128/JVI.00949-10
   PubMed Web of Science ®Google Scholar
• Fros JJ, van der Maten E, Vlak JM, et al. The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling. J Virol. 2013;87(18):10394–10400.10.1128/JVI.00884-13
   PubMed Web of Science ®Google Scholar
• Judith D, Mostowy S, Bourai M, et al. Species-specific impact of the autophagy machinery on Chikungunya virus infection. EMBO Rep. 2013;14(6):534–544.10.1038/embor.2013.51
   PubMed Web of Science ®Google Scholar
• Malet H, Coutard B, Jamal S, et al. The crystal structures of chikungunya and venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol. 2009;83(13):6534–6545.10.1128/JVI.00189-09
   PubMed Web of Science ®Google Scholar
• Panas MD, Ahola T, McInerney GM. The C-terminal repeat domains of nsP3 from the old world alphaviruses bind directly to G3BP. J Virol. 2014;88(10):5888–5893.10.1128/JVI.00439-14
   PubMed Web of Science ®Google Scholar
• Neuvonen M, Kazlauskas A, Martikainen M, et al. SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication. PLoS Pathog. 2011;7(11):e1002383.10.1371/journal.ppat.1002383
   PubMed Web of Science ®Google Scholar
• Chen MW, Tan YB, Zheng J, et al. Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities. Antiviral Res. 2017;143:38–47.10.1016/j.antiviral.2017.04.001
   PubMed Web of Science ®Google Scholar
• Leung JY, Ng MM, Chu JJ. Replication of alphaviruses: a review on the entry process of alphaviruses into cells. Adv Virol. 2011;2011:249640.
   PubMedGoogle Scholar
• Tang BL. The cell biology of Chikungunya virus infection. Cell Microbiol. 2012;14(9):1354–1363.10.1111/j.1462-5822.2012.01825.x
   PubMed Web of Science ®Google Scholar
• Lum FM, Ng LFP. Cellular and molecular mechanisms of chikungunya pathogenesis. Antiviral Res. 2015;120:165–174.10.1016/j.antiviral.2015.06.009
   PubMed Web of Science ®Google Scholar
• Vega-Rúa A, Schmitt C, Bonne I, et al. Chikungunya virus replication in salivary glands of the mosquito aedes albopictus. Viruses. 2015;7(11):5902–5907.10.3390/v7112917
   PubMed Web of Science ®Google Scholar
• Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet. 2012;379(9816):662–671.10.1016/S0140-6736(11)60281-X
   PubMed Web of Science ®Google Scholar
• Teng T-S, Kam Y-W, Tan JJ, et al. Host response to chikungunya virus and perspectives for immune-based therapies. Future Virol. 2011;6(8):975–984.10.2217/fvl.11.67
   Web of Science ®Google Scholar
• Nunes MRT, Faria NR, de Vasconcelos JM, et al. Emergence and potential for spread of chikungunya virus in Brazil. BMC Med. 2015;13:102.10.1186/s12916-015-0348-x
   PubMed Web of Science ®Google Scholar
• Lourenço-de-Oliveira R, Failloux AB. High risk for chikungunya virus to initiate an enzootic sylvatic cycle in the tropical Americas. PLoS Negl Trop Dis. 2017;11(6):e0005698.10.1371/journal.pntd.0005698
   PubMed Web of Science ®Google Scholar
• Vega-Rúa A, Zouache K, Girod R, et al. High level of vector competence of aedes aegypti and aedes albopictus from ten american countries as a crucial factor in the spread of chikungunya virus. J Virol. 2014;88(11):6294–6306.10.1128/JVI.00370-14
   PubMed Web of Science ®Google Scholar
• van Genderen FT, Krishnadath I, Sno R, et al. First chikungunya outbreak in suriname; clinical and epidemiological features. PLoS Negl Trop Dis. 2016;10(4):e0004625.10.1371/journal.pntd.0004625
   PubMed Web of Science ®Google Scholar
• Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re‐emerging infectious disease. Clin Infect Dis. 2009;49(6):942–948.10.1086/599189
   PubMed Web of Science ®Google Scholar
• Versteeg L, Febres MEC, Beaumier CM. The role of cellular immune responses on chikungunya virus infection-induced arthritis. Curr Trop Med Rep. 2016;3(2):60–66.10.1007/s40475-016-0074-2
   Google Scholar
• Chikungunya [internet]. World Health Organization. http://www.who.int/mediacentre/factsheets/fs327/en/.
   Google Scholar
• Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88:2363–2377.10.1099/vir.0.82858-0
   PubMed Web of Science ®Google Scholar
• Cassadou S, Boucau S, Huc MP, et al. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill. 2014;19(13):20752.10.2807/1560-7917.ES2014.19.13.20752
   PubMedGoogle Scholar
• Sá PKO, Nunes MM, Leite IR, et al. Chikungunya virus infection with severe neurologic manifestations: report of four fatal cases. Rev Soc Bras Med Trop. 2017;50(2):265–268.
   PubMed Web of Science ®Google Scholar
• Rodrigues NCP, Lino VTS, Daumas RP, et al. Temporal and spatial evolution of dengue incidence in Brazil, 2001–2012. PLoS One. 2016;11(11):e0165945.10.1371/journal.pone.0165945
   PubMed Web of Science ®Google Scholar
• Marques CDL, Duarte ALBP, Ranzolin A, et al. Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of chikungunya fever. Part 1 – Diagnosis and special situations. Rev Bras Reumatol. 2017;57(Suppl 2):421–437. 10.1016/j.rbr.2017.05.004
   Google Scholar
• Fares RCG, Souza KPR, Añez G, et al. Epidemiological scenario of Dengue in Brazil. BioMed Res Int. 2015;2015:321873.
   PubMedGoogle Scholar
• Monitoramento dos casos de dengue e febre de chickungunya até a Semana Epidemiológia 12, 2015 [internet]. Secretaria de Vigilância em Saúde - Ministério da Saúde - Brasil. Boletim Epidemiológico 2015;46(14):1–7. http://portalarquivos.saude.gov.br/images/pdf/2015/maio/04/2015-016–Boletim-Dengue-SE15-2015.pdf.
   Google Scholar
• Guia de vigilância em saúde [internet]. Brasília (Brazil): Secretaria de Vigilância em Saúde - Ministério da Saúde; 2017. http://portalarquivos.saude.gov.br/images/pdf/2017/outubro/06/Volume-Unico-2017.pdf.
   Google Scholar
• Peterson LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang. 2010;98(4):495–503.10.1111/vox.2010.98.issue-4
   PubMed Web of Science ®Google Scholar
• Brouard C, Bernillon P, Quatresous I, et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion. 2008;48:1333–1341.10.1111/trf.2008.48.issue-7
   PubMed Web of Science ®Google Scholar
• Robillard PY, Boumahni B, Gérardin P, et al. Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women. Presse Med. 2006;35(5):785–788.10.1016/S0755-4982(06)74690-5
   PubMed Web of Science ®Google Scholar
• Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the Island of La Réunion. PLoS Med. 2008;5(3):e60.10.1371/journal.pmed.0050060
   PubMed Web of Science ®Google Scholar
• Torres JR, Falleiros-Arlant LH, Dueñas L, et al. Congenital and perinatal complications of chikungunya fever: a Latin American experience. Int J Infect Dis. 2016;51:85–88.10.1016/j.ijid.2016.09.009
   PubMed Web of Science ®Google Scholar
• Bandeira AC, Campos GS, Sardi SI, et al. Neonatal encephalitis due to Chikungunya vertical transmission – First report in Brazil. IDCases. 2016;5:57–59.10.1016/j.idcr.2016.07.008
   PubMed Web of Science ®Google Scholar
• Tandale BV, Sathe PS, Arankalle VA, et al. Systemic involvements and fatalities during chikungunya epidemic in India, 2006. J Clin Virol. 2009;46(2):145–149.10.1016/j.jcv.2009.06.027
   PubMed Web of Science ®Google Scholar
• Cardona-Correa SE, Castaño-Jaramillo LM, Quevedo-Vélez A. Vertical transmission of chikungunya virus infection – case report. Rev Chil Pediatr. 2017;88(2):285–288.10.4067/S0370-41062017000200015
   PubMed Web of Science ®Google Scholar
• Miner JJ, Aw-Yeang HX, Fox JM, et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015;67(5):1214–1220.10.1002/art.39027
   PubMed Web of Science ®Google Scholar
• Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3(1):35.10.1186/1869-5760-3-35
   PubMedGoogle Scholar
• Simon F, Javelle E, Oliver M, et al. Chikungunya virus infection. Curr Infect Dis Rep. 2011;13(3):218–228.10.1007/s11908-011-0180-1
   PubMedGoogle Scholar
• Martínez-Pulgarín DF, Chowdhury FR, Villamil-Gomez WE, et al. Ophthalmologic aspects of chikungunya infection. Travel Med Infect Dis. 2016;14(5):451–457.10.1016/j.tmaid.2016.05.008
   PubMed Web of Science ®Google Scholar
• Alvarez MF, Bolívar-Mejía A, Rodriguez-Morales AJ, et al. Cardiovascular involvement and manifestations of systemic Chikungunya virus infection – a systematic review. F1000Res. 2017;6:390. 10.12688/f1000research
   PubMedGoogle Scholar
• Torres JR, Codova Códova GLG, Castro JS, et al. Chikungunya fever: atypical and lethal cases in the Western hemisphere – a Venezuelan experience. IDCases. 2015;2(1):6–10.10.1016/j.idcr.2014.12.002
   PubMed Web of Science ®Google Scholar
• Brizzi K. Neurologic manifestation of chikungunya virus. Curr Infect Dis Rep. 2017;19(2):6.10.1007/s11908-017-0561-1
   PubMed Web of Science ®Google Scholar
• Mohan A, Kiran DHN, Manohar ChiranjeeviIIC, et al. Epidemiology, clinical manifestations, and diagnosis of chikungunya fever: lessons learned from the re-emerging epidemic. Indian J Dermatol. 2010;55(1):54–63.10.4103/0019-5154.60355
   PubMedGoogle Scholar
• Hochedez P, Jaureguiberry S, Debruyne M, et al. Chikungunya infection in travelers. Emerg Infect Dis. 2006;12(10):1565–1567.10.3201/eid1210.060495
   PubMed Web of Science ®Google Scholar
• Marimoutou C, Vivier E, Oliver M, et al. Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island. Medicine (Baltimore). 2012;91(4):212–219.10.1097/MD.0b013e318260b604
   PubMed Web of Science ®Google Scholar
• Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137.10.1371/journal.pntd.0002137
   PubMed Web of Science ®Google Scholar
• Phuklia W, Kasisith J, Modhiran N, et al. Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res. 2013;177(2):179–188.10.1016/j.virusres.2013.08.011
   PubMed Web of Science ®Google Scholar
• Gérardin P, Couderc T, Binter M, et al. Chikungunya virus-associated encephalitis - A cohort study on La Réunion Island, 2005-2009. Neurology. 2016;86(1):94–102.10.1212/WNL.0000000000002234
   PubMed Web of Science ®Google Scholar
• Rajapakse S, Rodrigo C, Rajapakse A. Atypical manifestations of chikungunya infection. Trans R Soc Trop Med Hyg. 2010;104(2):89–96.10.1016/j.trstmh.2009.07.031
   PubMed Web of Science ®Google Scholar
• Ramful D, Carbonnier M, Pasquet M, et al. Mother-to-child transmission of chikungunya virus infection. Pediatr Infect Dis J. 2007;26(9):811–815.10.1097/INF.0b013e3180616d4f
   PubMed Web of Science ®Google Scholar
• Joob B, Wiwanitkit V, Joob B, et al. Neurological manifestations of Chikungunya. Arq Neuropsiquiatr. 2017;75(5):326.10.1590/0004-282x20170029
   PubMed Web of Science ®Google Scholar
• Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914–5927.10.4049/jimmunol.0900255
   PubMed Web of Science ®Google Scholar
• Sudeep AB, Parashar D. Chikungunya : an overview. J Biosci 2008;33(4):443–449. arthritis and bone pathology. Trends Microbiol. 2015;23(1):35–43.
   PubMedGoogle Scholar
• Lemant J, Boisson V, Winer A, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit Care Med. 2008;36(9):2536–2541.10.1097/CCM.0b013e318183f2d2
   PubMed Web of Science ®Google Scholar
• Kam YW, Ong EKS, Rénia L, et al. Immuno-biology of Chikungunya and implications for disease intervention. Microbes Infect. 2009;11:1186–1196.10.1016/j.micinf.2009.09.003
   PubMed Web of Science ®Google Scholar
• Kosasih H, de Mast Q, Widjaja S, et al. Evidence for endemic chikungunya virus infections in Bandung, Indonesia. PLos Negl Trop Dis. 2013;7(10):e2483.10.1371/journal.pntd.0002483
   PubMed Web of Science ®Google Scholar
• Sourisseau M, Schilte C, Casartelli N, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007;3(6):e89.10.1371/journal.ppat.0030089
   PubMed Web of Science ®Google Scholar
• Couderc T, Chrétien F, Schilte C, et al. A Mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4(2):e29.10.1371/journal.ppat.0040029
   PubMed Web of Science ®Google Scholar
• Prashant S, Kumar AS, Basheeruddin DDM, et al. Cutaneous manifestations in patients suspected of chikungunya disease. Indian J Dermatol. 2009;54(2):128–131.10.4103/0019-5154.53186
   PubMedGoogle Scholar
• Puiprom O, Morales Vargas RE, Potiwat R, et al. Characterization of chikungunya virus infection of a human keratinocyte cell line: role of mosquito salivary gland protein in suppressing the host immune response. Infect Genet Evol. 2013;17:210–215.10.1016/j.meegid.2013.04.005
   PubMed Web of Science ®Google Scholar
• Thon-Hon VG, Denizot M, Li-Pat-Yuen G, et al. Deciphering the differential response of two human fibroblast cell lines following chikungunya virus infection. Virol J. 2012;9:213.10.1186/1743-422X-9-213
   PubMed Web of Science ®Google Scholar
• Thangamani S, Higgs S, Ziegler S, et al. Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One. 2010;5(8):e12137.10.1371/journal.pone.0012137
   PubMed Web of Science ®Google Scholar
• Couderc T, Gangneux N, Chrétien F, et al. Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206(6):851–859.10.1093/infdis/jis296
   PubMed Web of Science ®Google Scholar
• Nhan T-X, Fallevoz T, De Pina J-J, et al. Chikungunya virus uveitis during French Polynesia outbreak, 2014-2015. J Clin Case Rep. 2016;6:1000682.
   Google Scholar
• Cerny T, Schwarz M, Schwarz U, et al. The range of neurological complications in chikungunya fever. Neurocrit Care. 2017;27(3):447–457.10.1007/s12028-017-0413-8
   PubMed Web of Science ®Google Scholar
• Chiam CW, Chan YF, Ong KC, et al. Neurovirulence comparison of Chikungunya virus isolates of the Asian and East/Central/South/African genotypes from Malaysia. J Gen Virol. 2015;96(11):3243–3254.10.1099/jgv.0.000263
   PubMedGoogle Scholar
• Inglis FM, Lee KM, Chiu KB, et al. Neuropathogenesis of chikungunya infection: astrogliosis and innate immune activation. 2016;22(2):140–148.
   Google Scholar
• Brito CA, Sohsten AK, Leitão CC, et al. Pharmacologic management of pain in patients with Chikungunya: a guideline. Rev Soc Bras Med Trop. 2016;49(6):668–679.10.1590/0037-8682-0279-2016
   PubMed Web of Science ®Google Scholar
• Hawman DW, Stoermer KA, Montgomery SA, et al. Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol. 2013;87(24):13878–13888.10.1128/JVI.02666-13
   PubMed Web of Science ®Google Scholar
• Reddy V, Mani RS, Desai A, et al. Correlation of plasma viral loads and presence of chikungunya IgM antibodies with cytokine/chemokine levels during acute chikungunya virus infection. J Med Virol. 2014;86(8):1393–1401.10.1002/jmv.v86.8
   PubMed Web of Science ®Google Scholar
• Pakran J, George M, Riyaz N, et al. Purpuric macules with vesiculobullous lesions: a novel manifestation of Chikungunya. Int J Dermatol. 2011;50(1):61–69.10.1111/ijd.2010.50.issue-1
   PubMed Web of Science ®Google Scholar
• Peiris JS, Porterfield JS. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature. 1979;282(5738):509–511.10.1038/282509a0
   PubMed Web of Science ®Google Scholar
• Lum FM, Couderc T, Chia BS, et al. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity. Sci Rep. 2018;8(1):1860.10.1038/s41598-018-20305-4
   PubMedGoogle Scholar
• Her Z, Malleret B, Chan M, et al. Active infection of human blood monocytes by chikungunya virus triggers an innate immune response. J Immunol. 2010;184(10):5903–5913.10.4049/jimmunol.0904181
   PubMed Web of Science ®Google Scholar
• Gasque P, Couderc T, Lecuit M, et al. Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis. 2015;15(4):241–249.10.1089/vbz.2014.1710
   PubMed Web of Science ®Google Scholar
• Schilte C, Couderc T, Chretien F, et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med. 2010;207(2):429–442.10.1084/jem.20090851
   PubMed Web of Science ®Google Scholar
• Ng LFP, Chow A, Sun YJ, et al. IL-1β, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One. 2009;4(1):e4261.10.1371/journal.pone.0004261
   PubMed Web of Science ®Google Scholar
• Wauquier N, Becquart P, Nkoghe D, et al. The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis. 2011;204(1):115–123.10.1093/infdis/jiq006
   PubMed Web of Science ®Google Scholar
• Kelvin AA, Banner D, Silvi G, et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis. 2011;5(8):e1279.10.1371/journal.pntd.0001279
   PubMed Web of Science ®Google Scholar
• Teng TS, Kam YW, Lee B, et al. A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection. J Infect Dis. 2015;211(12):1925–1935.10.1093/infdis/jiv049
   PubMed Web of Science ®Google Scholar
• Chow A, Her Z, Ong EKS, et al. Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis. 2011;203(2):149–157.10.1093/infdis/jiq042
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361(9):888–898.10.1056/NEJMra0707449
   PubMed Web of Science ®Google Scholar
• Chen W, Foo SS, Sims NA, et al. Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol. 2015 Jan;23(1):35–43.10.1016/j.tim.2014.09.005
   PubMed Web of Science ®Google Scholar
• Chaaithanya IK, Muruganandam N, Raghuraj U, et al. Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection. Indian J Med Res. 2014;140(1):142–145.
   PubMedGoogle Scholar
• Teo TH, Lum FM, Claser C, et al. A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J Immunol. 2013;190(1):259–269.10.4049/jimmunol.1202177
   PubMed Web of Science ®Google Scholar
• Das T, Jaffar-Bandjee MC, Hoarau JJ, et al. Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus. Prog Neurobiol. 2010;91(2):121–129.10.1016/j.pneurobio.2009.12.006
   PubMed Web of Science ®Google Scholar
• Goupil BA, Mores CN. A review of Chikungunya virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis. Open Rheumatol J. 2016;10:129–140.
   PubMedGoogle Scholar
• Johnson BW, Russell BJ, Goodman CH. Laboratory diagnosis of chikungunya virus infections and commercial sources for diagnostic assays. J Infect Dis. 2016;214(Suppl 5):S471–S474.10.1093/infdis/jiw274
   PubMedGoogle Scholar
• Lo Presti A, Lai A, Cella E, et al. Chikungunya virus, epidemiology, clinics and phylogenesis: a review. Asian Pac J Trop Med. 2014;7(12):925–932.10.1016/S1995-7645(14)60164-4
   PubMed Web of Science ®Google Scholar
• Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: case report and review of the literature. Semin Arthritis Rheum. 2013;43(2):273–278.10.1016/j.semarthrit.2013.03.003
   PubMed Web of Science ®Google Scholar
• Powers AM. Vaccine and therapeutic options to control Chikungunya virus. Clin Microbiol Rev. 2018;31(1):e00104–e00116.
   PubMed Web of Science ®Google Scholar
• Parashar D, Cherian S. Antiviral perspectives for chikungunya virus. Biomed Res Int. 2014;2014:631642.
   PubMed Web of Science ®Google Scholar
• Rothan HA, Bahrani H, Mohamed Z, et al. A combination of doxycycline and robaravin alleviated chikungunya infection. PLoS One. 2015;10(5):e0126360.10.1371/journal.pone.0126360
   PubMed Web of Science ®Google Scholar
• Abdelnabi R, Jochmans D, Verbeken E, et al. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antiviral Res. 2018;149:113–117.10.1016/j.antiviral.2017.09.016
   PubMed Web of Science ®Google Scholar
• Couderc T, Khandoudi N, Grandadam M, et al. Prophylaxis and therapy for chikungunya virus infection. J Infect Dis. 2009;200(4):516–523.10.1086/599176
   PubMed Web of Science ®Google Scholar
• Broeckel R, Fox JM, Haese N, et al. Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques. PLoS Negl Trop Dis. 2017;11(6):e0005637.10.1371/journal.pntd.0005637
   PubMed Web of Science ®Google Scholar
• Akahata W, Yang ZY, Andersen H, et al. A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection. Nat Med. 2010;16:334–338.10.1038/nm.2105
   PubMed Web of Science ®Google Scholar
• Brandler S, Tangy F. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Comp Immunol Microbiol Infect Dis. 2008;31(2–3):271–291.10.1016/j.cimid.2007.07.012
   PubMed Web of Science ®Google Scholar
• Plante K, Wang E, Partidos CD, et al. Novel chikungunya vaccine candidate with an ires-based attenuation and host range alteration mechanism. PLoS Pathog. 2011;7(7):e1002142.10.1371/journal.ppat.1002142
   PubMed Web of Science ®Google Scholar
• Chang LJ, Dowd KA, Mendoza FH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 2014;384(9959):2046–2052.10.1016/S0140-6736(14)61185-5
   PubMed Web of Science ®Google Scholar
• Goo L, Dowd KA, Lin TY, et al. A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes. J Infect Dis. 2016;214(10):1487–1491.10.1093/infdis/jiw431
   PubMed Web of Science ®Google Scholar